Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214707 · ClinicalTrials.gov registry record
Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy
A clinical trial, sponsored by Cyberonics.
- Completed
- Registry status
- 30
- Enrollment target
NCT01214707: Completed study, sponsored by Cyberonics.
NCT01214707 is a clinical trial that has completed, run by Cyberonics. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01214707 has completed, sponsored by Cyberonics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Characterization of the cardiac response (ECG) preceding an epileptic seizure.
Primary Outcome
Characterization of the cardiac response (ECG) to physiologic events and comparison to changes in heart rate that precede an epileptic seizure.
Interventions
- OTHER Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-09 |
What the finished NCT01214707 record still lists
NCT01214707 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.
NCT01214707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01214707 about?
NCT01214707 is a clinical study titled "Heart Rate Changes During Normal Activity, Exercise, and Seizures in Subjects With Epilepsy". Characterization of the cardiac response (ECG) preceding an epileptic seizure.
What is the current status of trial NCT01214707?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2010-09.
What interventions are being tested in trial NCT01214707?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT01214707?
This trial is sponsored by Cyberonics, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia